Skyrizi 150 MG/ML penml
Ended Awarded
- Contract number
- SPE2DR26FT781
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $69,800
Award facts
- Contract value 100% obligated
- $69,800.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Skyrizi 150 mg/ml pens, a pharmaceutical product used in dermatological treatment. This non-set-aside, competitively awarded contract carries a ceiling value of $69,800.26 and employs firm fixed pricing, with an ultimate completion date of November 12, 2025. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen Drug Corp's corporate headquarters. This delivery order is issued as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the DLA's Medical Supply Chain. The company's comprehensive IDC vehicle enables it to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and the U.S. Coast Guard. The award of this delivery order demonstrates the company's continued capability to fulfill federal pharmaceutical procurement requirements through open competition and reflects its established role as a primary supplier within the DLA's pharmaceutical distribution network.
Quick answers
Who was awarded contract SPE2DR26FT781?
SPE2DR26FT781 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DR26FT781 worth?
The government has obligated $69,800 on SPE2DR26FT781.
Is contract SPE2DR26FT781 an order under another contract?
Yes. SPE2DR26FT781 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FT781 competed?
The extent of competition for SPE2DR26FT781 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award